StockWatch
·
Pharmaceuticals
Management Change30 Apr 2026, 04:20 pm

Laurus Labs Appoints Two New Independent Directors, One Retires

AI Summary

Laurus Labs Ltd's Board of Directors, at their meeting on April 30, 2026, approved the appointment of Dr. Shekhar Chintamani Mande and Ms. Sutapa Banerjee as Independent Directors. Both appointments are for a term of five consecutive years, effective from July 02, 2026, and are subject to shareholder approval. Dr. Mande is a distinguished structural and computational biologist and former Director General of CSIR. Ms. Banerjee's profile was also annexed. The Board also noted the retirement of Mrs. Aruna Bhinge as an Independent Director, effective from the close of business hours on July 6, 2026, upon completion of her second term. The new appointees are confirmed to be unrelated to any existing directors or Key Managerial Personnel and are not debarred by any regulatory authority.

Key Highlights

  • Laurus Labs' Board approved two new Independent Directors.
  • Dr. Shekhar Chintamani Mande and Ms. Sutapa Banerjee appointed for 5 years.
  • Appointments are effective July 2, 2026, pending shareholder approval.
  • Mrs. Aruna Bhinge will retire as Independent Director on July 6, 2026.
  • New directors are independent and not related to company management.